[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].
Identifieur interne : 000303 ( PubMed/Corpus ); précédent : 000302; suivant : 000304[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].
Auteurs : T. Bach ; T. Bschleipfer ; R. MuschterSource :
- Der Urologe. Ausg. A [ 1433-0563 ] ; 2013.
English descriptors
- KwdEn :
- MESH :
- diagnosis : Prostatic Hyperplasia.
- surgery : Prostatic Hyperplasia.
- trends : Laser Therapy, Minimally Invasive Surgical Procedures, Prostatectomy.
- Humans, Male.
Abstract
Open simple prostatectomy is not only the oldest but also the most effective treatment option for benign prostatic obstruction. Laser enucleation has been established as a transurethral minimally invasive alternative especially but not exclusively for large volume prostates. To date two laser systems, holmium:YAG laser enucleation of the prostate (HoLEP) and thulium:YAG laser vapoenucleation of the prostate (ThuVEP) have been established. Both treatment modalities have similarities in terms of wavelength and surgical technique but differ in the type of energy released (pulsed versus continuous wave). The HoLEP and ThuVEP procedures lead to a significant improvement in symptoms, quality of life, urinary flow and post-void residual urine. Surgery-related morbidity, especially bleeding complications is significantly reduced with laser enucleation. For HoLEP the durability of the results was shown for a follow-up interval of up to 10 years while for ThuVEP the follow-up interval reached 18 months due to the shorter time since clinical implementation of this method.
DOI: 10.1007/s00120-013-3114-8
PubMed: 23429881
Links to Exploration step
pubmed:23429881Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].</title><author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name><affiliation><nlm:affiliation>Urologischen Zentrums Harburg, Minimal-Invasive Urologie und Lasertherapie, Asklepios Klinik Harburg, Eißendorfer Pferdeweg 52, 21075 Hamburg, Deutschland. t.bach@asklepios.com</nlm:affiliation></affiliation></author><author><name sortKey="Bschleipfer, T" sort="Bschleipfer, T" uniqKey="Bschleipfer T" first="T" last="Bschleipfer">T. Bschleipfer</name></author><author><name sortKey="Muschter, R" sort="Muschter, R" uniqKey="Muschter R" first="R" last="Muschter">R. Muschter</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2013">2013</date><idno type="doi">10.1007/s00120-013-3114-8</idno><idno type="RBID">pubmed:23429881</idno><idno type="pmid">23429881</idno><idno type="wicri:Area/PubMed/Corpus">000303</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000303</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].</title><author><name sortKey="Bach, T" sort="Bach, T" uniqKey="Bach T" first="T" last="Bach">T. Bach</name><affiliation><nlm:affiliation>Urologischen Zentrums Harburg, Minimal-Invasive Urologie und Lasertherapie, Asklepios Klinik Harburg, Eißendorfer Pferdeweg 52, 21075 Hamburg, Deutschland. t.bach@asklepios.com</nlm:affiliation></affiliation></author><author><name sortKey="Bschleipfer, T" sort="Bschleipfer, T" uniqKey="Bschleipfer T" first="T" last="Bschleipfer">T. Bschleipfer</name></author><author><name sortKey="Muschter, R" sort="Muschter, R" uniqKey="Muschter R" first="R" last="Muschter">R. Muschter</name></author></analytic><series><title level="j">Der Urologe. Ausg. A</title><idno type="eISSN">1433-0563</idno><imprint><date when="2013" type="published">2013</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Humans</term><term>Laser Therapy (trends)</term><term>Male</term><term>Minimally Invasive Surgical Procedures (trends)</term><term>Prostatectomy (trends)</term><term>Prostatic Hyperplasia (diagnosis)</term><term>Prostatic Hyperplasia (surgery)</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Prostatic Hyperplasia</term></keywords><keywords scheme="MESH" qualifier="trends" xml:lang="en"><term>Laser Therapy</term><term>Minimally Invasive Surgical Procedures</term><term>Prostatectomy</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Humans</term><term>Male</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Open simple prostatectomy is not only the oldest but also the most effective treatment option for benign prostatic obstruction. Laser enucleation has been established as a transurethral minimally invasive alternative especially but not exclusively for large volume prostates. To date two laser systems, holmium:YAG laser enucleation of the prostate (HoLEP) and thulium:YAG laser vapoenucleation of the prostate (ThuVEP) have been established. Both treatment modalities have similarities in terms of wavelength and surgical technique but differ in the type of energy released (pulsed versus continuous wave). The HoLEP and ThuVEP procedures lead to a significant improvement in symptoms, quality of life, urinary flow and post-void residual urine. Surgery-related morbidity, especially bleeding complications is significantly reduced with laser enucleation. For HoLEP the durability of the results was shown for a follow-up interval of up to 10 years while for ThuVEP the follow-up interval reached 18 months due to the shorter time since clinical implementation of this method.</div></front></TEI><pubmed><MedlineCitation Owner="NLM" Status="MEDLINE"><PMID Version="1">23429881</PMID><DateCreated><Year>2013</Year><Month>03</Month><Day>18</Day></DateCreated><DateCompleted><Year>2013</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2014</Year><Month>11</Month><Day>20</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1433-0563</ISSN><JournalIssue CitedMedium="Internet"><Volume>52</Volume><Issue>3</Issue><PubDate><Year>2013</Year><Month>Mar</Month></PubDate></JournalIssue><Title>Der Urologe. Ausg. A</Title><ISOAbbreviation>Urologe A</ISOAbbreviation></Journal><ArticleTitle>[Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].</ArticleTitle><Pagination><MedlinePgn>345-9</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s00120-013-3114-8</ELocationID><Abstract><AbstractText>Open simple prostatectomy is not only the oldest but also the most effective treatment option for benign prostatic obstruction. Laser enucleation has been established as a transurethral minimally invasive alternative especially but not exclusively for large volume prostates. To date two laser systems, holmium:YAG laser enucleation of the prostate (HoLEP) and thulium:YAG laser vapoenucleation of the prostate (ThuVEP) have been established. Both treatment modalities have similarities in terms of wavelength and surgical technique but differ in the type of energy released (pulsed versus continuous wave). The HoLEP and ThuVEP procedures lead to a significant improvement in symptoms, quality of life, urinary flow and post-void residual urine. Surgery-related morbidity, especially bleeding complications is significantly reduced with laser enucleation. For HoLEP the durability of the results was shown for a follow-up interval of up to 10 years while for ThuVEP the follow-up interval reached 18 months due to the shorter time since clinical implementation of this method.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bach</LastName><ForeName>T</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Urologischen Zentrums Harburg, Minimal-Invasive Urologie und Lasertherapie, Asklepios Klinik Harburg, Eißendorfer Pferdeweg 52, 21075 Hamburg, Deutschland. t.bach@asklepios.com</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bschleipfer</LastName><ForeName>T</ForeName><Initials>T</Initials></Author><Author ValidYN="Y"><LastName>Muschter</LastName><ForeName>R</ForeName><Initials>R</Initials></Author></AuthorList><Language>ger</Language><PublicationTypeList><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Operative Therapie der benignen Prostatahyperplasie : Enukleierende Verfahren (HoLEP und ThuVEP).</VernacularTitle></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Urologe A</MedlineTA><NlmUniqueID>1304110</NlmUniqueID><ISSNLinking>0340-2592</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D053685">Laser Therapy</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D008297">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D019060">Minimally Invasive Surgical Procedures</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011468">Prostatectomy</DescriptorName><QualifierName MajorTopicYN="Y" UI="Q000639">trends</QualifierName></MeshHeading><MeshHeading><DescriptorName MajorTopicYN="N" UI="D011470">Prostatic Hyperplasia</DescriptorName><QualifierName MajorTopicYN="N" UI="Q000175">diagnosis</QualifierName><QualifierName MajorTopicYN="Y" UI="Q000601">surgery</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2013</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2013</Year><Month>2</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2013</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="doi">10.1007/s00120-013-3114-8</ArticleId><ArticleId IdType="pubmed">23429881</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/ThuliumV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000303 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000303 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= ThuliumV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:23429881
|texte= [Operative therapy of benign prostatic hyperplasia: enucleation procedures (HoLEP and ThuVEP)].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:23429881" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a ThuliumV1
| This area was generated with Dilib version V0.6.21. |  |